📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Safety, Tolerability, and Pharmacokinetics of SMT C1100, a 2-Arylbenzoxazole Utrophin Modulator, following Single- and Multiple-Dose Administration to Pediatric Patients with Duchenne Muscular Dystrophy. (2016)

First Author: Ricotti V

Attributed to: MICA: The role of utrophin in DMD and its therapeutic potential funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1371/journal.pone.0152840

PubMed Identifier: 27055247

Publication URI: http://europepmc.org/abstract/MED/27055247

Type: Journal Article/Review

Volume: 11

Parent Publication: PloS one

Issue: 4

ISSN: 1932-6203